Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, October 29, 2021
[ Fri, Oct 29th 2021
] - WOPRAI
[ Fri, Oct 29th 2021
] - WOPRAI
[ Fri, Oct 29th 2021
] - WOPRAI
[ Fri, Oct 29th 2021
] - WOPRAI
[ Fri, Oct 29th 2021
] - WOPRAI
[ Fri, Oct 29th 2021
] - WOPRAI
[ Fri, Oct 29th 2021
] - WOPRAI
[ Fri, Oct 29th 2021
] - WOPRAI
[ Fri, Oct 29th 2021
] - WOPRAI
[ Fri, Oct 29th 2021
] - WOPRAI
[ Fri, Oct 29th 2021
] - WOPRAI
[ Fri, Oct 29th 2021
] - WOPRAI
[ Fri, Oct 29th 2021
] - WOPRAI
[ Fri, Oct 29th 2021
] - WOPRAI
[ Fri, Oct 29th 2021
] - WOPRAI
[ Fri, Oct 29th 2021
] - WOPRAI
[ Fri, Oct 29th 2021
] - WOPRAI
[ Fri, Oct 29th 2021
] - WOPRAI
[ Fri, Oct 29th 2021
] - WOPRAI
[ Fri, Oct 29th 2021
] - WOPRAI
[ Fri, Oct 29th 2021
] - WOPRAI
Thu, October 28, 2021
[ Thu, Oct 28th 2021
] - WOPRAI
[ Thu, Oct 28th 2021
] - WOPRAI
[ Thu, Oct 28th 2021
] - WOPRAI
[ Thu, Oct 28th 2021
] - WOPRAI
[ Thu, Oct 28th 2021
] - WOPRAI
[ Thu, Oct 28th 2021
] - WOPRAI
[ Thu, Oct 28th 2021
] - WOPRAI
[ Thu, Oct 28th 2021
] - WOPRAI
[ Thu, Oct 28th 2021
] - WOPRAI
Brian Abrahams Initiated (XENE) at Buy and Held Target at $43 on, Oct 28th, 2021
Brian Abrahams of RBC Capital, Initiated "Xenon Pharmaceuticals Inc." (XENE) at Buy and Held Target at $43 on, Oct 28th, 2021.
Brian has made no other calls on XENE in the last 4 months.
There is 1 other peer that has a rating on XENE. Out of the 1 peers that are also analyzing XENE, 0 agree with Brian's Rating of Hold.
This is the rating of the analyst that currently disagrees with Brian
- Serge Belanger of "Needham" Maintained at Strong Buy with Increased Target to $48 on, Monday, October 4th, 2021
